Automated Propensity Scoring for Medical Treatment Evaluation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for analyzing the effects of medical treatments are limited by high costs, reliance on large numbers of test subjects, ineffectiveness in identifying secondary interactions, and manual modeling processes that are prone to bias and human error, especially when dealing with retrospective cohort studies and large datasets.
Innovation Solution
A computer-implemented system and method for evaluating medical treatments using patient record data, which includes propensity scoring and doubly robust estimation to determine the relative likelihood of treatment effects by weighting patient cases based on their likelihood of being in the treatment group, thereby balancing confounding factors and improving accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If manual modeling processes are used to control for confounders in historical patient record data, then the analysis can be performed with existing data, but the results are highly dependent on operator expertise and prone to bias and human error
Solution Approach 1:
The system performs automated propensity score calculation and weighting without requiring manual statistical modeling by operators. The computer automatically calculates propensity scores from patient characteristics and applies inverse probability weighting, making the analysis independent of operator expertise while maintaining or improving result quality.
Solution Approach 2:
The patent replaces manual statistical modeling processes with automated computer-based calculations. Instead of operators manually selecting and adjusting confounders, the system uses algorithmic propensity score matching and inverse probability weighting to objectively balance treatment groups, eliminating human bias and error.
2Reliability
If randomized controlled trials are used to evaluate treatment effects, then the analysis is simplified by evenly distributing confounding factors, but the cost is high and large numbers of test subjects are required
Solution Approach 1:
The system creates a synthetic control group by calculating propensity scores from historical patient data and using inverse probability weighting to replicate the characteristics of a randomized control trial. This allows evaluation of treatment effects using existing patient records without requiring new randomized trials with large subject numbers.
Solution Approach 2:
The patent transforms retrospective observational data into a structure that mimics randomized controlled trials by applying propensity score weighting. This parameter transformation allows the system to achieve confounder balance similar to RCTs while using existing historical data rather than recruiting new subjects.
3Measurement precision
If manual confounder control processes are used in retrospective cohort studies, then the analysis can identify treatment effects, but the process is very time intensive and subject to human error
Solution Approach 1:
The patent replaces time-consuming manual confounder control processes with automated computer-based propensity score calculations. The system automatically identifies relevant patient characteristics, calculates propensity scores, and applies inverse probability weighting, dramatically reducing the time required while improving precision by eliminating human error.
Solution Approach 2:
The system performs the entire confounder control process automatically without requiring manual statistical modeling. The computer independently calculates propensity scores from patient data and applies appropriate weighting, making the process efficient and reproducible without dependence on operator skill or time investment.
Data Source
AI summary
A computer-implemented system and method of evaluating the effects of medical treatments, the method including receiving patient record data; identifying relevant characteristics for evaluation; identifying a first treatment; identifying a second treatment; assigning a weight to each patient case; determining the relative likelihood, using the assigned weights, that an identified treatment will result in an identified effect when contrasted with a second identified treatment; and, outputting this estimated relative likelihood.